Switching to Aflibercept in Diabetic Macular Edema after Unsatisfactory Response to Other Anti-vascular Endothelial Growth Factor Drugs.

CONCLUSIONS: Switching to aflibercept in DME patients with an unsatisfactory response to previous anti-VEGF injections provided acceptable short-term visual and retinal architectural improvement. PMID: 30977321 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30977321?dopt=Abstract

Source: Korean Journal of Ophthalmology : KJO - April 14, 2019 Category: Opthalmology Tags: Korean J Ophthalmol Source Type: research